Johns Hopkins University at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Johns Hopkins University takes part in 2 sessions at CTAD 2026 in Boston. Its program centres on new biomarker sources, from NPTX2-centred proteomics in CSF and plasma to needle-free sampling of the olfactory lining.

Organization	CTAD 2026 Attendance
Johns Hopkins University Baltimore, Maryland
	Poster Wed Nov 18 7:15am–5:30pm NPTX2-Centered Interaction-State Proteomics in Cerebrospinal Fluid and Plasma Reveals Biofluid-Specific Signatures of Alzheimer’s Disease (P222) Blood and CSF biomarkers Poster Wed Nov 18 7:15am–5:30pm Needle-free biomarker detection platform using the olfactory neuroepithelium: superiority to blood-based assays in Alzheimer’s disease (P260) Blood and CSF biomarkers

Organization

CTAD 2026 Attendance

Johns Hopkins University

Baltimore, Maryland

Poster

Wed Nov 18
7:15am–5:30pm

NPTX2-Centered Interaction-State Proteomics in Cerebrospinal Fluid and Plasma Reveals Biofluid-Specific Signatures of Alzheimer’s Disease (P222)

Blood and CSF biomarkers

Poster

Wed Nov 18
7:15am–5:30pm

Needle-free biomarker detection platform using the olfactory neuroepithelium: superiority to blood-based assays in Alzheimer’s disease (P260)

Blood and CSF biomarkers

Instantly find 20 buyers from Johns Hopkins University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction